Could targeting secretory leukocyte protease inhibitor be an effective therapeutic option to prevent infections in acute liver failure?

Lucia A Possamai; Wafa Khamri; Evangelos Triantafyllou; Julia A Wendon; Mark R Thursz; Charalambos G Antoniades

doi:10.2217/imt.14.49

Could targeting secretory leukocyte protease inhibitor be an effective therapeutic option to prevent infections in acute liver failure?

Lucia A Possamai, Wafa Khamri, Evangelos Triantafyllou, Julia A Wendon, Mark R Thursz, Charalambos G Antoniades

King's College London

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	667-9
Number of pages	3
Journal	Immunotherapy
Volume	6
Issue number	6
DOIs	https://doi.org/10.2217/imt.14.49
Publication status	Published - 2014

Keywords

Humans
Liver Failure, Acute
Molecular Targeted Therapy
Risk Assessment
Risk Factors
Secretory Leukocyte Peptidase Inhibitor
Sepsis
Signal Transduction

Access to Document

10.2217/imt.14.49

Cite this

@article{dc265a1680e2454f89fd89b00ad03c9c,

title = "Could targeting secretory leukocyte protease inhibitor be an effective therapeutic option to prevent infections in acute liver failure?",

keywords = "Humans, Liver Failure, Acute, Molecular Targeted Therapy, Risk Assessment, Risk Factors, Secretory Leukocyte Peptidase Inhibitor, Sepsis, Signal Transduction",

author = "Possamai, {Lucia A} and Wafa Khamri and Evangelos Triantafyllou and Wendon, {Julia A} and Thursz, {Mark R} and Antoniades, {Charalambos G}",

year = "2014",

doi = "10.2217/imt.14.49",

language = "English",

volume = "6",

pages = "667--9",

journal = "Immunotherapy",

issn = "1750-743X",